NeueHealth (NYSE:NEUE) Posts Earnings Results, Misses Expectations By $5.12 EPS

NeueHealth (NYSE:NEUE) released its quarterly earnings results on Thursday. The company reported ($7.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12), Zacks reports. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%.

NeueHealth Price Performance

NYSE:NEUE traded up $0.45 during mid-day trading on Thursday, reaching $5.29. The stock had a trading volume of 10,345 shares, compared to its average volume of 19,330. The stock has a 50-day simple moving average of $7.11 and a two-hundred day simple moving average of $6.00. The stock has a market capitalization of $43.79 million, a PE ratio of -0.10 and a beta of 0.56. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.66.

Insiders Place Their Bets

In other NeueHealth news, CFO Jay Matushak sold 4,970 shares of the business’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10. Following the sale, the chief financial officer now owns 17,747 shares of the company’s stock, valued at approximately $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO George Lawrence Mikan III sold 12,440 shares of the business’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $6.13, for a total transaction of $76,257.20. Following the completion of the sale, the chief executive officer now directly owns 249,454 shares in the company, valued at approximately $1,529,153.02. This represents a 4.75 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 110,033 shares of company stock valued at $774,560. 64.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.